Dr. Lam Tsun Ho - General Practice
General Practice
Highlights
- MCHK RegisteredVerified
- QualificationsBachelor of Medicine and Bachelor of Surgery (MBBS) · Medical degree 2019
- InsuranceBeing compiled｜See details
About
Dr. Lam Tsun Ho is a registered medical practitioner in Hong Kong.
Education
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2019
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Lam Tsun Ho? Claim page and update insurance →
Hospital Affiliations
Referrals available to these hospitals
FAQ
Is Dr. Lam Tsun Ho any good?
Dr. Lam Tsun Ho is a registered medical practitioner in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Lam Tsun Ho do?
Dr. Lam Tsun Ho practises in General Practice.
Are you Dr. Lam Tsun Ho? Claim this page to update and manage.
ClaimResearch and publications
10 papers
- UNICORN for Valve-in-Valve Transcatheter Aortic Valve Replacement: UNICORN Hong Kong Registry.JACC. Asia · 2026
- Percutaneous antegrade retrieval of an atrial septal occluder dislodged into the left ventricle.The Journal of invasive cardiology · 2026
- Safety and Efficacy of Concomitant Nirmatrelvir/Ritonavir and Direct Oral Anticoagulant Therapies for COVID-19 Among Patients With Atrial Fibrillation.Journal of the American Heart Association · 2026
- Cardiovascular safety of 5-fluorouracil and capecitabine in colorectal cancer patients: real-world evidence.Cardio-oncology (London, England) · 2025
- Atherosclerotic plaque, cardiovascular risk, and lipid-lowering strategies: a narrative review.Frontiers in cardiovascular medicine · 2025
- Transcatheter closure of right coronary cusp aneurysm-to-right ventricle paravalvular leak in a patient with complex congenital heart disease.The Journal of invasive cardiology · 2025
- Group G Streptococcus Infective Endocarditis Complicated by a Very Delayed Coronary Embolism.JACC. Case reports · 2025
- Aromatase Inhibitor Therapy Increases the Risk of New-Onset Atrial Fibrillation in Patients With Breast Cancer.JACC. Asia · 2024
- Editorial: Cardiovascular complications of emerging oncological therapies.Frontiers in cardiovascular medicine · 2024
- Immunopathogenesis of Immune Checkpoint Inhibitor Induced Myocarditis: Insights from Experimental Models and Treatment Implications.Biomedicines · 2023
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer